Better Therapeutics, Inc is a San Francisco-based company that is revolutionizing the treatment of cardiometabolic diseases through their prescription digital therapeutics platform, AspyreRx. Their clinically validated and FDA regulated mobile applications deliver cognitive behavioral therapy digitally, providing accessible and on-demand treatment without the need for in-person visits or specialized healthcare professionals.
With a focus on type 2 diabetes, Better Therapeutics utilizes proprietary CBT techniques to target cognitive patterns that drive eating and lifestyle behaviors, while AI technology ensures personalized treatment plans for each individual. Their evidence-based approach has shown statistically significant reductions in A1c levels, and their platform has garnered high engagement and satisfaction rates among users.
Generated from the website